Cite
Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies
MLA
M A, Roggero, et al. “Plasmodium Falciparum CS C-Terminal Fragment: Preclinical Evaluation and Phase I Clinical Studies.” Parassitologia, vol. 41, no. 1–3, Mar. 2000. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........dc9038151dd2605088de88e2d178fb08&authtype=sso&custid=ns315887.
APA
M A, R., C, W., A, B., R, A., J, R., F, S., G, C., & J A, L. (2000). Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies. Parassitologia, 41(1–3).
Chicago
M A, Roggero, Weilenmann C, Bonelo A, Audran R, Renggli J, Spertini F, Corradin G, and López J A. 2000. “Plasmodium Falciparum CS C-Terminal Fragment: Preclinical Evaluation and Phase I Clinical Studies.” Parassitologia 41 (1–3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........dc9038151dd2605088de88e2d178fb08&authtype=sso&custid=ns315887.